Health and Healthcare

Celgene : CELG

CELG

Stock Data

$108.24

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All CELG Articles

433 Articles

Jon C. Ogg | Dec 13, 2019 at 9:55 AM EST

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Independent research firm Argus sees better than 25% potential upside for Bristol-Myers Squibb in the coming year.

Chris Lange | Nov 12, 2019 at 10:00 AM EST

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data…

Chris Lange | Oct 25, 2019 at 10:05 AM EDT

Major Biotechs See Rising Tide in Short Interest

The October 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Oct 10, 2019 at 10:00 AM EDT

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data…

Chris Lange | Sep 25, 2019 at 9:30 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 12, 2019 at 8:40 AM EDT

Major Biotechs Scare Off Short Sellers

The August 30 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 28, 2019 at 11:20 AM EDT

7 Giant Mergers Transforming the Face of Corporate America

Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and…

Chris Lange | Aug 27, 2019 at 9:15 AM EDT

Short Sellers Hike Their Bets in Biotech

The August 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 26, 2019 at 3:20 PM EDT

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:50 AM EDT

Short Sellers Make a Move on Big Biotechs

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 25, 2019 at 8:40 AM EDT

Major Biotechs See Rising Tide in Short Interest

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 24, 2019 at 10:20 AM EDT

Why Jounce Therapeutics Popped

Jounce Therapeutics shares jumped on Wednesday after the company announced an update on its strategic collaboration with Celgene. This collaboration…

Chris Lange | Jul 11, 2019 at 9:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data…

Chris Lange | Jun 26, 2019 at 10:05 AM EDT

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these…

1 2 3 … 29

Celgene : CELG

CELG

$108.24

All CELG Articles

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Major Biotechs See Rising Tide in Short Interest

Major Biotechs See Rising Tide in Short Interest

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

7 Giant Mergers Transforming the Face of Corporate America

Short Sellers Hike Their Bets in Biotech

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Major Biotechs See Rising Tide in Short Interest

Why Jounce Therapeutics Popped

Short Sellers Run for Cover From Major Biotechs

Big Biotechs Scare Off Short Sellers

Can AppLovin Become A $1 Trillion Company

Rocket Lab’s $554M Revenue Dwarfs AST SpaceMobile’s $18M Despite Identical $30B Valuations

Reddit’s Top AI Stocks: Why Traders Are Backing IBM and ASML Over other AI Plays

Suze Orman vs. Dave Ramsey on Social Security: Who’s Right?

Social Security Cost Of Living Adjustment (COLA) Changes After Fed Cuts Rates Again

Can AppLovin Become A $1 Trillion Company

Rocket Lab’s $554M Revenue Dwarfs AST SpaceMobile’s $18M Despite Identical $30B Valuations

Celgene : CELG

CELG

$108.24

All CELG Articles

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Major Biotechs See Rising Tide in Short Interest

Major Biotechs See Rising Tide in Short Interest

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

7 Giant Mergers Transforming the Face of Corporate America

Short Sellers Hike Their Bets in Biotech

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Major Biotechs See Rising Tide in Short Interest

Why Jounce Therapeutics Popped

Short Sellers Run for Cover From Major Biotechs

Big Biotechs Scare Off Short Sellers

Can AppLovin Become A $1 Trillion Company

Rocket Lab’s $554M Revenue Dwarfs AST SpaceMobile’s $18M Despite Identical $30B Valuations

Reddit’s Top AI Stocks: Why Traders Are Backing IBM and ASML Over other AI Plays

Featured Reads

Suze Orman vs. Dave Ramsey on Social Security: Who’s Right?

Social Security Cost Of Living Adjustment (COLA) Changes After Fed Cuts Rates Again